Volume 22, Number 7—July 2016
Research
Tropheryma whipplei as a Cause of Epidemic Fever, Senegal, 2010–2012
Table 1
Clinical manifestations observed in 786 febrile Tropheryma whipplei–positive or –negative patients in 2 villages, Dielmo and Ndiop in the Sine-Saloum area of Senegal, June 2010–March 2012.
Clinical manifestation | T. whipplei–positive patients, no. (%), n = 36 | T. whipplei–negative patients, no. (%), n = 750 | p value by χ2 test |
---|---|---|---|
Headache | 23 (68.9) | 439 (58.5) | 0.52 |
Arthralgia | 0 | 19 (2.5) | 0.46 |
Myalgia | 0 | 53 (7.0) | 0.07 |
Diarrhea | 3 (8.3) | 39 (5.2) | 0.3 |
Vomiting | 4 (11.1) | 94 (12.5) | 0.56 |
Nausea | 5 (13.9) | 100 (13.3) | 0.53 |
Abdominal pain | 1 (2.8) | 21 (2.8) | 0.68 |
Cough | 13 (36.1) | 274 (36.5) | 0.95 |
Expectoration | 2 (5.6) | 42 (5.6) | 0.67 |
Otalgia | 1 (2.8) | 28 (3.7) | 0.61 |
Otorrhea | 0 | 2 (0.3) | 0.91 |
Rhinorrhea | 8 (22.2) | 229 (30.5) | 0.28 |
Burning urination | 1 (2.8) | 33 (4.4) | 0.53 |
Rash | 0 | 10 (1.3) | 0.62 |
Meningeal signs | 2 (5.5) | 25 (3.3) | 0.35 |
Page created: June 14, 2016
Page updated: June 14, 2016
Page reviewed: June 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.